AIG vs EDIT · P/E 21, rev $7.18B vs rev $32.3M
American International Group Inc (AIG) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
American International Group Inc (AIG) is a insurance - diversified company listed on US.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported AIG revenue for 2024-12-31 was $7.18B. Net income was $901.0M. Revenue was up 6.3% from 2024-09-30 to 2024-12-31. AIG currently screens at market cap $48.97B and trailing P/E 20.6.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
AIG currently screens at market cap $48.97B and trailing P/E 20.6. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the AIG and EDIT stock pages for the full models.
Not investment advice.